Kathmandu : Several government and private hospitals in Kathmandu have rolled out strict restrictions on Medical Representatives (MRs), citing ethical business practices and high footfalls that are disrupting hospital services. The move has ignited heated debate across Nepal’s healthcare and pharmaceutical sectors.

Nepal’s health sector and pharmaceutical market have expanded rapidly over the past few decades. Medical Representatives, professionals who bridge pharmaceutical companies and doctors, have served as the backbone of this growth.

Equipped with scientific and technical knowledge, MRs update physicians on new drugs, their efficacy, pharmacokinetics, potential side effects, and clinical benefits, supporting informed treatment decisions.

High Footfalls and Ethical Concerns

In recent weeks, various hospitals have limited or banned MR entry into Outpatient Departments (OPD) and hospital premises. Administrations argue that frequent visits cause overcrowding, obstruct smooth service delivery, and raise questions about ethical promotional practices.

Some facilities, such as Bir Hospital, have explicitly barred MRs from OPDs, emergency wards and patient areas during office hours to maintain focus on patient care.

Importance of MRs in the Healthcare Ecosystem

Despite the restrictions, MRs play a vital role in hospital society. They facilitate the flow of up-to-date information on emerging therapies in a resource-constrained environment, support continuous medical education and help ensure timely availability of medicines.

Many doctors rely on them for scientific updates that keep clinical practice current. Critics of the blanket approach argue that completely shutting doors risks isolating healthcare professionals from pharmaceutical advancements without providing structured alternatives like digital portals or scheduled sessions.

Livelihoods and Human Resource Crisis

The policy has triggered alarm over its socio-economic fallout. Industry estimates suggest more than 10,000 highly educated youths work as MRs nationwide.

Entry typically requires a bachelor’s degree in Science or Pharmacy. These professionals, many of whom chose to build careers in Nepal, now face sudden uncertainty.

Nepal already struggles with high youth unemployment. With over 500,000 young people entering the job market annually, only a fraction secure suitable domestic roles.

Losing these 10,000 skilled positions could push thousands onto the streets and endanger the economic security of 40,000–50,000 family members who depend on them.

Risk of Brain Drain and Remittance Trap

This development comes at a time when Nepal’s economy remains heavily reliant on remittances. Thousands of youths depart daily via Tribhuvan International Airport for opportunities abroad.

Restricting a respectable, skill-based sector risks accelerating brain drain, forcing technically qualified MRs into foreign employment or intellectual migration. Such a step appears to contradict government rhetoric on “creating domestic employment” and “curbing youth exodus.”

Instead of strengthening the local workforce, the decision could transform Nepal into a nation depleted of productive young talent.

Need for Balanced Solutions

While concerns over ethical business practices and operational disruptions are legitimate and align with global efforts to regulate pharmaceutical promotion, stakeholders call for measured responses rather than outright bans.

Possible middle-ground measures include designated visiting hours, mandatory registration systems, transparent codes of conduct aligned with the Department of Drug Administration’s ethical guidelines and technology driven information sharing.

As Nepal’s healthcare infrastructure grows, preserving the productive role of MRs while addressing ethics and efficiency will be crucial. How authorities navigate this tension will impact not only patient care and medical practice but also youth employment and the broader economy.

The issue is likely to intensify as pharmaceutical companies, MR associations, and affected professionals engage with policymakers.